Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013

Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 
28, 2013 
MONTREAL, Jan. 31, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. 
(NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and 
a live Internet webcast along with a slide presentation on Thursday, February 
28, 2013 at 8:00 a.m. ET (5:00 a.m. PT) to discuss results for the 2012 fourth 
quarter. 
The dial-in number to participate on this call is (877) 295-5743, confirmation 
code 94189232.  International callers should dial (973) 200-3961, confirmation 
code 94189232. A replay will be available approximately two hours following 
the conclusion of the conference call to Thursday, March 7, 2013, and can be 
accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 
94189232. 
The webcast and slide presentation will be hosted in the investor relations 
section of its corporate Web site at www.valeant.com. Participants should 
allow approximately five to 10 minutes prior to the call's start time to visit 
the site and to download any streaming media software needed to listen to the 
Internet webcast. An online archive of the webcast will be available following 
the end of the live call in the webcast archive portion of the investor 
relations section at www.valeant.com. 
About Valeant  Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is 
a multinational specialty pharmaceutical company that develops, manufactures 
and markets a broad range of pharmaceutical products primarily in the areas of 
dermatology, neurology and branded generics.  More information about Valeant 
can be found at www.valeant.com. 
Contact Information: Laurie W. Little  949-461-6002  laurie.little@valeant.com 
(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) 
http://www.valeant.com 
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO 
PRN Photo Desk, photodesk@prnewswire.com 
SOURCE: Valeant Pharmaceuticals International, Inc. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/January2013/31/c2041.html 
CO: Valeant Pharmaceuticals International, Inc.
NI: HEA FIN MTC CONF  
-0- Jan/31/2013 13:01 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.